Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
DiaMedica Therapeutics, Inc. (DMAC) had Free Cash Flow per Share of $-0.17 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-10.04M |
|
-- |
|
-- |
|
$10.48M |
|
$-10.48M |
|
$0.45M |
|
$-10.04M |
|
$-10.04M |
|
$-10.04M |
|
$-10.04M |
|
$-10.04M |
|
$-10.04M |
|
$-10.48M |
|
$-10.66M |
|
53.79M |
|
53.79M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$52.36M |
|
$0.14M |
|
$0.72M |
|
$53.08M |
|
$5.75M |
|
$0.00M |
|
$0.10M |
|
$5.84M |
|
$47.23M |
|
$47.23M |
|
$47.23M |
|
53.88M |
|
| Cash Flow Statement Financials | |
$-9.08M |
|
$-2.11M |
|
$0.42M |
|
$15.65M |
|
$4.87M |
|
$-10.78M |
|
$0.82M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.11 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.09M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-21.26% |
|
-21.26% |
|
-18.92% |
|
-21.26% |
|
$0.88 |
|
|
Free Cash Flow per Share |
$-0.17 |
$-0.17 |
|